Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people wit… Read more
Onward Medical N.V. (ONWD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.679x
Based on the latest financial reports, Onward Medical N.V. (ONWD) has a cash flow conversion efficiency ratio of -0.679x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-18.81 Million) by net assets (€27.72 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Onward Medical N.V. - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Onward Medical N.V.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Onward Medical N.V. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Onward Medical N.V. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IM Vinaria Purcari SRL
RO:WINE
|
-0.002x |
|
Liton Technology
TWO:6175
|
0.050x |
|
PT Bank Bisnis Internasional Tbk
JK:BBSI
|
0.085x |
|
Autopistas del Sol
BA:AUSO
|
0.016x |
|
Toyo Kanetsu K.K
F:TQ2
|
0.023x |
|
Humana AB
LSE:0RF7
|
0.028x |
|
Humana AB (publ)
ST:HUM
|
0.096x |
|
MMTEC Inc
NASDAQ:MTC
|
0.170x |
Annual Cash Flow Conversion Efficiency for Onward Medical N.V. (2018–2024)
The table below shows the annual cash flow conversion efficiency of Onward Medical N.V. from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €48.05 Million | €-31.76 Million | -0.661x | +63.27% |
| 2023-12-31 | €17.93 Million | €-32.27 Million | -1.800x | -254.95% |
| 2022-12-31 | €52.63 Million | €-26.68 Million | -0.507x | -110.94% |
| 2021-12-31 | €82.68 Million | €-19.87 Million | -0.240x | -159.80% |
| 2020-12-31 | €-32.09 Million | €-12.90 Million | 0.402x | -39.07% |
| 2019-12-31 | €-14.92 Million | €-9.85 Million | 0.660x | -5.33% |
| 2018-12-31 | €-10.27 Million | €-7.16 Million | 0.697x | -- |